Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Recruiting 18Completed 14Unknown 12Active not recruiting 7Terminated 6Not yet recruiting 5Withdrawn 2Suspended 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 2mCRC 1Neutropenia 1Advanced Microsatellite Stable Colorectal Cancer 1Advanced Colorectal Cancer 1

Interventions

Carboplatin 79Cisplatin 74Bevacizumab 62Radiotherapy 59Drug Therapy 57Capecitabine 57Oxaliplatin 56tislelizumab 54toripalimab 45Paclitaxel 44Gemcitabine 43Specimen Handling 41pembrolizumab 40anlotinib 40sintilimab 37Cyclophosphamide 34130-nm albumin-bound paclitaxel 34Injections 29Pemetrexed 28camrelizumab 26Surgical Procedures, Operative 26Magnetic Resonance Spectroscopy 26lenvatinib 24apatinib 23Docetaxel 23Etoposide 22Biopsy 22S 1 (combination) 21Fluorouracil 21Immune Checkpoint Inhibitors 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × trifluridine tipiracil drug combination × Clear all
NCT07527858 2026-04-14

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

Gilead Sciences

Phase 2 Not yet recruiting
170 enrolled
Gastrointestinal

Advanced Microsatellite Stable Colorectal Cancer

NCT07381764 2026-02-02

ROMANCE - GOIM

Gruppo Oncologico Italia Meridionale

Phase 2 Not yet recruiting
150 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07116577 2025-08-11

Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC

Jinan Central Hospital

Phase 2 Not yet recruiting
37 enrolled

mCRC

NCT07071844 2025-07-17

BETWEEN

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Not yet recruiting
162 enrolled
Gastrointestinal

Neutropenia, Colorectal Neoplasms

NCT05364489 2022-05-20

Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer

The First Affiliated Hospital of Zhengzhou University

Phase 2 Not yet recruiting
20 enrolled
Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡